Decoding and Unlocking the BCL-2 Dependency of Cancer Cells

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2013 Jun 21

PMID 23783119

Citations 113

Authors

Philippe Juin

Olivier Geneste

Fabien Gautier

Stephane Depil

Mario Campone

Affiliations

Soon will be listed here.

Abstract

Cancer cells are subject to many apoptotic stimuli that would kill them were it not for compensatory prosurvival alterations. BCL-2-like (BCL-2L) proteins contribute to such aberrant behaviour by engaging a network of interactions that is potent at promoting survival but that is also fragile: inhibition of a restricted number of interactions may suffice to trigger cancer cell death. Currently available and novel compounds that inhibit these interactions could be efficient therapeutic agents if this phenotype of BCL-2L dependence was better understood at a molecular, cellular and systems level and if it could be diagnosed by relevant biomarkers.

Citing Articles

Deoxyelephantopin induces apoptosis and cell cycle arrest in GL261 glioblastoma cells.

Lan C, Chen H, Sheu J Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39254878 DOI: 10.1007/s00210-024-03429-5.

Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity.

Gong Q, Li C, Wang H, Cao J, Li Z, Zhou M ACS Omega. 2024; 9(25):27369-27396.

PMID: 38947842 PMC: 11209699. DOI: 10.1021/acsomega.4c02021.

Canonical and Noncanonical Functions of the BH3 Domain Protein Bid in Apoptosis, Oncogenesis, Cancer Therapeutics, and Aging.

Makinwa Y, Luo Y, Musich P, Zou Y Cancers (Basel). 2024; 16(12).

PMID: 38927905 PMC: 11202167. DOI: 10.3390/cancers16122199.

Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts.

Nocquet L, Roul J, Lefebvre C, Duarte L, Campone M, Juin P Sci Rep. 2024; 14(1):14177.

PMID: 38898061 PMC: 11187150. DOI: 10.1038/s41598-024-64696-z.

Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance.

Grasset E, Barille-Nion S, Juin P Dis Model Mech. 2024; 17(3).

PMID: 38506114 PMC: 10979546. DOI: 10.1242/dmm.050542.

References

Gautier F, Guillemin Y, Cartron P, Gallenne T, Cauquil N, Le Diguarher T . Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL. Mol Cell Biol. 2010; 31(4):832-44. PMC: 3028639. DOI: 10.1128/MCB.00161-10. View

Akgul C . Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2008; 66(8):1326-36. PMC: 11131550. DOI: 10.1007/s00018-008-8637-6. View

Chen L, Willis S, Wei A, Smith B, Fletcher J, Hinds M . Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005; 17(3):393-403. DOI: 10.1016/j.molcel.2004.12.030. View

Mills J, Hippo Y, Robert F, Chen S, Malina A, Lin C . mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci U S A. 2008; 105(31):10853-8. PMC: 2504845. DOI: 10.1073/pnas.0804821105. View

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View

Czabotar P, Westphal D, Dewson G, Ma S, Hockings C, Fairlie W . Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell. 2013; 152(3):519-31. DOI: 10.1016/j.cell.2012.12.031. View

Kale J, Liu Q, Leber B, Andrews D . Shedding light on apoptosis at subcellular membranes. Cell. 2012; 151(6):1179-84. DOI: 10.1016/j.cell.2012.11.013. View

Gavathiotis E, Reyna D, Bellairs J, Leshchiner E, Walensky L . Direct and selective small-molecule activation of proapoptotic BAX. Nat Chem Biol. 2012; 8(7):639-45. PMC: 3617124. DOI: 10.1038/nchembio.995. View

Oltersdorf T, Elmore S, Shoemaker A, Armstrong R, Augeri D, Belli B . An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005; 435(7042):677-81. DOI: 10.1038/nature03579. View

10.

Ryder C, McColl K, Zhong F, Distelhorst C . Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor Gpr65 signaling to Mek/Erk. J Biol Chem. 2012; 287(33):27863-75. PMC: 3431637. DOI: 10.1074/jbc.M112.384685. View

11.

Braun F, Bertin-Ciftci J, Gallouet A, Millour J, Juin P . Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition. PLoS One. 2011; 6(8):e23577. PMC: 3160893. DOI: 10.1371/journal.pone.0023577. View

12.

Liu X, Dai S, Zhu Y, Marrack P, Kappler J . The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity. 2003; 19(3):341-52. DOI: 10.1016/s1074-7613(03)00234-6. View

13.

Degterev A, Boyce M, Yuan J . A decade of caspases. Oncogene. 2003; 22(53):8543-67. DOI: 10.1038/sj.onc.1207107. View

14.

Juin P, Hueber A, Littlewood T, Evan G . c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 1999; 13(11):1367-81. PMC: 316765. DOI: 10.1101/gad.13.11.1367. View

15.

Lee J, Innes Jr D, Williams M . Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest. 1989; 84(5):1454-9. PMC: 304009. DOI: 10.1172/JCI114320. View

16.

Lee M, Hirai I, Wang H . Caspase-3-mediated cleavage of Rad9 during apoptosis. Oncogene. 2003; 22(41):6340-6. DOI: 10.1038/sj.onc.1206729. View

17.

Chonghaile T, Sarosiek K, Vo T, Ryan J, Tammareddi A, Gaizo Moore V . Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science. 2011; 334(6059):1129-33. PMC: 3280949. DOI: 10.1126/science.1206727. View

18.

Wei M, Zong W, Cheng E, LINDSTEN T, Panoutsakopoulou V, Ross A . Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292(5517):727-30. PMC: 3049805. DOI: 10.1126/science.1059108. View

19.

Letai A, Bassik M, Walensky L, Sorcinelli M, Weiler S, Korsmeyer S . Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002; 2(3):183-92. DOI: 10.1016/s1535-6108(02)00127-7. View

20.

Kelly P, Grabow S, Delbridge A, Strasser A, Adams J . Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice. Blood. 2011; 118(24):6380-6. PMC: 3236120. DOI: 10.1182/blood-2011-07-367672. View